These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2012-000067-25 Protocol ALL-11: Treatment study protocol of the Dutch Childhood Oncology Group for children and adolescents (1-19 year) with newly diagnosed acute lymphoblastic leukemia Protocol ALL-11: Protocol... 2023-05-30 due-trials
Listed as ongoing, but also has a completion date 2016-004674-17 A pilot study to test the feasibility, safety and efficacy of the addition of the BiTE antibody Blinatumomab to the Interfant-06 backbone in infants with MLL-rearranged acute lympfoblastic leukemia ... 2024-03-07 bad-data
Reported results 2017-002738-22 Double blind placebo controlled randomized intervention study to validate the beneficial effect of hydrocortisone on dexamethasone-induced neurobehavioral side effects in pediatric acute lymphoblastic... 2021-03-27 due-trials
Exempt 2018-000698-54 A phase I/II post cord blood HCT dendritic cells vaccination trial directed against WT1 for pediatric and young adult acute myeloid leukemia: the U-DANCE-anti-AML trial Een fase I/II onderzoek naar... not-yet-due
Reported results 2019-003713-33 Diagnostic accuracy of neuroblastoma patient imaging with [18F]-mFBG PET-CT compared to [123]I-mIBG scanning Diagnostische nauwkeurigheid van beeldvorming van neuroblastoompatiënten met [18F]mFBG ... 2021-08-02 due-trials
Exempt 2020-000142-34 A Phase Ib study of Vyxeos® (liposomal daunorubicin and cytarabine) in combination with Clofarabine in children with relapsed/refractory AML, ITCC-092 not-yet-due
Other 2020-000508-13 An open-label, randomized clinical trial on teicoplanin infection prophylaxis in pediatric patients with acute myeloid leukemia not-yet-due
Reported results Terminated 2020-000509-96 Near-infrared fluorescence imaging using indocyanine green as an adjunct to improve standard-of-care sentinel lymph node procedure in pediatric patients with melanoma or sarcoma of head/neck/trunk, pa... 2023-11-03 due-trials
Other 2021-000213-16 International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia not-yet-due
Ongoing 2021-002713-34 A Phase I/II study of Brigatinib in pediatric and young adult patients with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or other solid tumors not-yet-due
Other 2021-003212-11 A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML not-yet-due
Ongoing 2021-003311-26 DAVINCY trial: optimal Duration of (fos)aprepitant prophylaxis for nausea and Vomiting INduced by ChemotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial’ D... not-yet-due
Reported results 2021-003388-90 Prospective monitoring of immune response following COVID-19 vaccination in children with cancer 2023-05-31 due-trials
Other 2021-003398-79 International proof of concept therapeutic Stratification trial of Molecular Anomalies in Relapsed or Refractory HEMatological malignancies in children Subprotocol D: Trametinib + Dexamethasone + Cycl... not-yet-due
Ongoing 2022-001811-16 68Ga-SATO in pediatric neuroblastoma patient; exploratory, safety, non-randomized, open label, comparative study 68Ga-SATO in pediatrische neuroblastoom patiënten; een verkennende, veiligheid, nie... not-yet-due
Ongoing 2022-002885-34 CHIP-AML22 Master protocol: An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium not-yet-due